Skip to content

SCHEDULE 13D/AAccepted Apr 16, 3:48 PM ET

Lantern Pharma Inc. SCHEDULE 13D/A

Bios Equity Partners, LP

sec.gov(opens the filing on sec.gov)

Accepted (ET)

3:48 PM

Apr 16, 2026

Filed

Apr 16, 2026

Documents

1

Size

35.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.